BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Qurient Announces Collaboration Agreement with MSD

Q901 is a novel highly selective CDK7 inhibitor Q901 is ready for dose escalation study in the U.S. for the treatment of selected advanced solid tumors ...

September 19, 2022 | News

Juniper Biologics signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East

Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...

September 02, 2022 | News

Merck to Acquire Chemical Business of Mecaro

Acquisition supports “Level Up” growth ambition of Merck’s Electronics business to further expand its regional capabilities and global ...

August 18, 2022 | News

Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study of BBT-877

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotechnology company developing novel drugs for cancer, fibrosis and inflammation, announ...

August 17, 2022 | News

ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis

ROKIT Healthcare, a company specializing in bio-healthcare, today announced it will provide a hyper-personalized medical platform that uses 3D bioprinting ...

August 15, 2022 | News

LG Chem Enters Final Stage of Clinical Development for New Gout Drug

In global Phase 3 clinical trial, Tigulixostat will be evaluated in 350 adult gout patients with hyperuricemia for safety and efficacy at Month 6 of treatm...

August 04, 2022 | News

GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine

GreenLight's messenger RNA production process is transferable to large-scale equipment and CMO facilities Technology transfer and scale-up from lab benc...

August 02, 2022 | News

GenKOre develops hypercompact adenine base editors (ABEs)

GenKOre (homepage: www.genkore.com) is a business spun off from the Korea Research Institute of Bioscience and Biotechnology (KRIBB), which is a gover...

August 02, 2022 | News

Baxter Makes Diabetic Retinopathy Screening Simple and Affordable for Primary Care Settings

Diabetic retinopathy is the leading cause of blindness among working-age adults globally.1 With early detection and treatment, as much as 95 percent o...

July 25, 2022 | News

AI-based Cancer Solution Pioneer Lunit Makes Market Debut

Lunit expects to raise approximately KRW 36.4 billion (US$ 28 million). Lunit intends to use the proceeds for R&D of its new AI products and ...

July 22, 2022 | News

Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug

As many Korean pharmaceutical manufacturers are currently attempting to develop new drugs for idiopathic pulmonary fibrosis, Daewoong Pharmaceutical's new ...

July 21, 2022 | News

Seegene launches world's first In-life PCR campaign in Vietnam

Test center LabHouse and ride-hailing service Grab to start PCR testing for Grab drivers in August Seegene to provide Allplex™ SARS-CoV-2/FluA/Flu...

July 20, 2022 | News

Samsung Biologics to purchase land for its second Bio Campus

Acquires additional land, sized 357,366㎡ valued at KRW 426 billion, for Bio Campus 2 Plans to build Multi-Modal Plant, Open Innovation,...

July 19, 2022 | News

Merck Launches its Uptune Program in Asia for Collaborating with Startups

Application period for the Merck Uptune program starts today Topics vary from AI-enabled health and cell and gene therapy tools to innovative technologi...

July 15, 2022 | News

Stay Connected